glp-1 alabama David S. Fieno, M.D. op-ed: Weight-loss medication coverage would mean a healthier GLP1 Elevate™ - GLP-1 Booster

Currently, Wegovy is the only medication approved for long-term weight management that also reduces cardiovascular risk

Compounded medications referenced in this article - including compounded semaglutide and compounded tirzepatide - are not FDA-approved finished drug products and have not been reviewed by the FDA for safety, effectiveness, or quality before marketing

Patients should be counseled on proper injection technique, storage requirements, and the importance of gradual dose escalation

People who take this for a long time should stay under a doctor's care

Lawsuits are being filed by people who say they lost their vision after using these drugs

Several studies have concluded that Wegovy can lead to significant weight loss when taken for an extended period